Ausgabe 6/2021
Inhalt (43 Artikel)
Reply to: Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring
Alexios S. Antonopoulos, Charalambos Antoniades
PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
Laura Evangelista, Pierpaolo Alongi
Clinical perspectives for the use of total body PET/CT
Ronan Abgral, David Bourhis, Pierre-Yves Salaun
SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists
Luca Giovanella, Rosaria M. Ruggeri, Petra Petranović Ovčariček, Alfredo Campenni, Giorgio Treglia, Desiree Deandreis
Medical imaging in times of pandemic: focus on the cornerstones of successful imaging
Roberto C. Delgado Bolton, Adriana K. Calapaquí Terán, Paola A. Erba, Francesco Giammarile
NEMA NU2-2012 performance measurements of the United Imaging uPMR790: an integrated PET/MR system
Shuguang Chen, Yushen Gu, Haojun Yu, Xin Chen, Tuoyu Cao, Lingzhi Hu, Hongcheng Shi
Systematic imaging in medicine: a comprehensive review
Kai Zhang, Yujie Sun, Shuang Wu, Min Zhou, Xiaohui Zhang, Rui Zhou, Tingting Zhang, Yuanxue Gao, Ting Chen, Yao Chen, Xin Yao, Yasuyoshi Watanabe, Mei Tian, Hong Zhang
[11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates
Laura Kuebler, Sabrina Buss, Andrei Leonov, Sergey Ryazanov, Felix Schmidt, Andreas Maurer, Daniel Weckbecker, Anne M. Landau, Thea P. Lillethorup, Daniel Bleher, Ran Sing Saw, Bernd J. Pichler, Christian Griesinger, Armin Giese, Kristina Herfert
[18F]-JK-PSMA-7 and [18F]-FDG tumour PET uptake in treated xenograft human prostate cancer model in mice
Gaetan Van Simaeys, Gilles Doumont, Coraline De Maeseneire, Nicolas Passon, Simon Lacroix, Cédric Lentz, Arnaud Horion, Corentin Warnier, David Torres, Corentin Martens, Irina Vierasu, Dominique Egrise, Serge Goldman
Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment
Nina J. Wesdorp, Tessa Hellingman, Elise P. Jansma, Jan-Hein T. M. van Waesberghe, Ronald Boellaard, Cornelis J. A. Punt, Joost Huiskens, Geert Kazemier
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
L. Papp, C. P. Spielvogel, B. Grubmüller, M. Grahovac, D. Krajnc, B. Ecsedi, R. A.M. Sareshgi, D. Mohamad, M. Hamboeck, I. Rausch, M. Mitterhauser, W. Wadsak, A. R. Haug, L. Kenner, P. Mazal, M. Susani, S. Hartenbach, P. Baltzer, T. H. Helbich, G. Kramer, S.F. Shariat, T. Beyer, M. Hartenbach, M. Hacker
Quantification of perivascular inflammation does not provide incremental prognostic value over myocardial perfusion imaging and calcium scoring
Susan Bengs, Ahmed Haider, Geoffrey I. Warnock, Michael Fiechter, Yves Pargaetzi, Georgios Rampidis, Dominik Etter, Winandus J. Wijnen, Angela Portmann, Elena Osto, Valerie Treyer, Dominik C. Benz, Alexander Meisel, Tobias A. Fuchs, Christoph Gräni, Ronny R. Buechel, Philipp A. Kaufmann, Aju P. Pazhenkottil, Catherine Gebhard
Prognostic value of SPECT myocardial perfusion entropy in high-risk type 2 diabetic patients
Loïc Djaileb, Alexandre Seiller, Marjorie Canu, Nicolas De Leiris, Alix Martin, Julie Poujol, Alicia Fraguas-Rubio, Julien Leenhardt, Adrien Carabelli, Alex Calizzano, Marie De Fondaumière, Alexis Broisat, Michel Desvignes, Gérald Vanzetto, Catherine Ghezzi, Daniel Fagret, Laurent M. Riou, Gilles Barone-Rochette
Cardiac transthyretin amyloidosis 99mTc-DPD SPECT correlates with strain echocardiography and biomarkers
Viktor Löfbacka, Jan Axelsson, Björn Pilebro, Ole B. Suhr, Per Lindqvist, Torbjörn Sundström
A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis
Yu Iwabuchi, Masashi Kameyama, Yohji Matsusaka, Hidetoshi Narimatsu, Masahiro Hashimoto, Morinobu Seki, Daisuke Ito, Hajime Tabuchi, Yoshitake Yamada, Masahiro Jinzaki
Improved amyloid burden quantification with nonspecific estimates using deep learning
Haohui Liu, Ying-Hwey Nai, Francis Saridin, Tomotaka Tanaka, Jim O’ Doherty, Saima Hilal, Bibek Gyanwali, Christopher P. Chen, Edward G. Robins, Anthonin Reilhac
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation
Dan Cohen, Shir Hazut Krauthammer, Ido Wolf, Einat Even-Sapir
Comparison of MRI, [18F]FDG PET/CT, and 99mTc-UBI 29-41 scintigraphy for postoperative spondylodiscitis—a prospective multicenter study
Diana Paez, Mike M. Sathekge, Hassan Douis, Francesco Giammarile, Shazia Fatima, Anil Dhal, Sunil K. Puri, Paola A. Erba, Elena Lazzeri, Rodolfo Ferrando, Paulo Almeida Filho, Vincent Peter Magboo, Olga Morozova, Rodolfo Núñez, Olivier Pellet, Giuliano Mariani
Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis
K. S. M. van der Geest, G. Treglia, A. W. J. M. Glaudemans, E. Brouwer, F. Jamar, R. H. J. A. Slart, O. Gheysens
Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smell
Maxime Niesen, Nicola Trotta, Antoine Noel, Tim Coolen, Georges Fayad, Gil Leurkin-Sterk, Isabelle Delpierre, Sophie Henrard, Niloufar Sadeghi, Jean-Christophe Goffard, Serge Goldman, Xavier De Tiège
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
Ayca Løndalen, Johan Blakkisrud, Mona-Elisabeth Revheim, Ulf Erik Madsbu, Jostein Dahle, Arne Kolstad, Caroline Stokke
Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers
Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, Vasko S. Kramer, Frank Roesch, Samta Kumari, Madhavi Tripathi, Sreedharan Thankarajan ArunRaj, Sulochana Sarswat, Chandrasekhar Bal
Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
Christos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, Dimitrios Papamichail, Uwe Haberkorn, Jessica C. Hassel, Antonia Dimitrakopoulou-Strauss
Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT
Liang Zhao, Yizhen Pang, Zuoming Luo, Kaili Fu, Tingting Yang, Long Zhao, Long Sun, Hua Wu, Qin Lin, Haojun Chen
Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes
Eike Steidl, Karl-Josef Langen, Sarah Abu Hmeidan, Nenad Polomac, Christian P. Filss, Norbert Galldiks, Philipp Lohmann, Fee Keil, Katharina Filipski, Felix M. Mottaghy, Nadim Jon Shah, Joachim P. Steinbach, Elke Hattingen, Gabriele D. Maurer
Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer
Hui Tan, Xiuli Sui, Hongyan Yin, Haojun Yu, Yusen Gu, Shuguang Chen, Pengcheng Hu, Wujian Mao, Hongcheng Shi
PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis
Pierpaolo Biondetti, Mark G. Vangel, Rita M. Lahoud, Felipe S. Furtado, Bruce R. Rosen, David Groshar, Lina G. Canamaque, Lale Umutlu, Eric W. Zhang, Umar Mahmood, Subba R. Digumarthy, Jo-Anne O. Shepard, Onofrio A. Catalano
Uncovering the invisible—prevalence, characteristics, and radiomics feature–based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer
Constantinos Zamboglou, Alisa S. Bettermann, Christian Gratzke, Michael Mix, Juri Ruf, Selina Kiefer, Cordula A. Jilg, Matthias Benndorf, Simon Spohn, Thomas F. Fassbender, Peter Bronsert, Mengxia Chen, Hongqian Guo, Feng Wang, Xuefeng Qiu, Anca-Ligia Grosu
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer
Nicolas Aide, Pauline Fauchille, Elodie Coquan, Gwenael Ferron, Pierre Combe, Jérome Meunier, Jerôme Alexandre, Dominique Berton, Alexandra Leary, Gaétan De Rauglaudre, Nathalie Bonichon, Eric Pujade Lauraine, Florence Joly
Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
Mubarik A. Arshad, Samuel Gitau, Henry Tam, Won-Ho E. Park, Neva H. Patel, Andrea Rockall, Eric O. Aboagye, Nishat Bharwani, Tara D. Barwick
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy
Kerstin Michalski, Juri Ruf, Christian Goetz, Anna Katharina Seitz, Andreas K. Buck, Constantin Lapa, Philipp E. Hartrampf
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
L. M. Mittlmeier, M. Unterrainer, S. Rodler, A. Todica, N. L. Albert, C. Burgard, C. C. Cyran, W. G. Kunz, J. Ricke, P. Bartenstein, C. G. Stief, H. Ilhan, M. Staehler
[18F]DCFPyL PET/CT in detection and localization of recurrent prostate cancer following prostatectomy including low PSA < 0.5 ng/mL
Elisa Perry, Arpit Talwar, Kim Taubman, Michael Ng, Lih-Ming Wong, Russell Booth, Tom R. Sutherland
Whole-body parametric [18F]-FDG PET/CT improves interpretation of a distant lesion as venous embolus in a lung cancer patient
Michael Messerli, Fotis Kotasidis, Daniela A. Ferraro, Ken Kudura, Valerie Treyer, Josephine Trinckauf, Corina Weyermann, Martin Hüllner, Philipp Kaufmann, Irene A. Burger
18F-FDG PET/CT and MRI findings of Shulman syndrome also known as eosinophilic fasciitis
Juliette Barlet, Alexandre Virone, Léa Gomez, Clovis Adam, Xavier Mariette, Emmanuel Durand, Florent L. Besson
[68Ga]Ga-FAPI and [18F]FDG PET/CT images in a patient with juvenile polymyositis
Jieling Zheng, Huaning Chen, Kaixian Lin, Shaobo Yao, Weibing Miao
[68Ga]Ga-DOTA-FAPI-04 PET/CT imaging of benign pulmonary solitary fibrous tumour
Huipan Liu, Lin Liu, Lin Chen, Yan Zhao, Wei Zhang, Liang Cai, Yue Chen
68Ga-FAPI outperforms 18F-FDG PET/CT in identifying solitary fibrous tumor
Rongxi Wang, Qingxing Liu, Huimin Sui, Mu Zhang, Zhaohui Zhu, Ruixue Cui
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
Ann-Christin Eder, Mohamed A. Omrane, Sven Stadlbauer, Mareike Roscher, Wael Y. Khoder, Christian Gratzke, Klaus Kopka, Matthias Eder, Philipp T. Meyer, Cordula A. Jilg, Juri Ruf
Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT
Katharina Dendl, Stefan A. Koerber, Sebastian Adeberg, Manuel Röhrich, Clemens Kratochwil, Uwe Haberkorn, Frederik L. Giesel
[18F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma - Catch me if you scan
Yogev Cohen, Albert Grinshpun, Karen Meir, Jeremy Godefroy
Correction to: 68Ga-FAPI outperforms 18F-FDG PET/CT in identifying solitary fibrous tumor
Rongxi Wang, Qingxing Liu, Huimin Sui, Mu Zhang, Zhaohui Zhu, Ruixue Cui
Correction to: [18F]FDG -PET/CT uptake reveals a single metastasis inside vertebral hemangioma, catch me if you scan
Yogev Cohen, Albert Grinshpun, Karen Meir, Jeremy Godefroy